DT Investment Partners’s GSK GSK Stock Holding History

DT Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$69.8K	Hold	1,331	–	–	0.01%	233
2026 Q1	$73.5K	Hold	1,331	–	–	0.01%	215
2025 Q4	$65.3K	Hold	1,331	–	–	0.01%	237
2025 Q3	$57.4K	Hold	1,331	–	–	﹤0.01%	224
2025 Q2	$51.1K	Hold	1,331	–	–	﹤0.01%	231
2025 Q1	$51.6K	Hold	1,331	–	–	0.01%	231
2024 Q4	$45K	Hold	1,331	–	–	﹤0.01%	242
2024 Q3	$54.4K	Hold	1,331	–	–	﹤0.01%	243
2024 Q2	$51.2K	Hold	1,331	–	–	﹤0.01%	232
2024 Q1	$57.1K	Hold	1,331	–	–	0.01%	217
2023 Q4	$52K	Hold	1,331	–	–	0.01%	220
2023 Q3	$48.2K	Hold	1,331	–	–	0.01%	206
2023 Q2	$46.5K	Hold	1,331	–	–	0.01%	214
2023 Q1	$48.2K	Hold	1,331	–	–	0.01%	206
2022 Q4	$46.8K	Hold	1,331	–	–	0.01%	205
2022 Q3	$39K	Buy	+1,331	New	+$50.4K	0.01%	210

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

DT Investment Partners's GSK Position: Q2 2026 in Review

DT Investment Partners held its GSK (GSK) position steady in Q2 2026 at 1,331 shares worth $69.8K. The position accounts for 0.01% of the portfolio, ranked #233.

DT Investment Partners first reported a position in GSK in Q3 2022 and has held it in 16 quarters since. The position peaked at $73.5K in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

DT Investment Partners held 1,331 shares of GSK worth $69.8K as of Q2 2026.
DT Investment Partners left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of DT Investment Partners's portfolio in Q2 2026, its #233 holding.
DT Investment Partners first reported a position in GSK in Q3 2022 and has held it in 16 quarters since.
DT Investment Partners's GSK position peaked at $73.5K in Q1 2026.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.